Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by EllaMae


ATNM

Kevin Harrington Discusses FSD Pharma

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 13, 2023

SLCH

Kevin Harrington Discusses FSD Pharma

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 13, 2023

TNXP

Kevin Harrington Discusses FSD Pharma

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 13, 2023

TNXP

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

  FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On...

July 15, 2022

SLCH

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

  FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On...

July 15, 2022

ATNM

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

  FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On...

July 15, 2022

ATNM

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

SLCH

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

TNXP

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

TNXP

FSD Pharma Files Investigational New Drug Application “IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 2, 2022

SLCH

FSD Pharma Files Investigational New Drug Application “IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 2, 2022

ATNM

FSD Pharma Files Investigational New Drug Application “IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 2, 2022

ATNM

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   ...

May 11, 2022

SLCH

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   ...

May 11, 2022

TNXP

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   ...

May 11, 2022

ATNM

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

May 3, 2022

SLCH

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

May 1, 2022

TNXP

FSD Pharma Inc: Lucid MS Video

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 30, 2022

ATNM

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John...

April 26, 2022

SLCH

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John...

April 24, 2022

1 2 3 4 Next

Featured Company